文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物

中国上海耐多药结核分枝杆菌传播:全基因组测序与流行病学回顾性观察研究

Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation.
PubMed 文献 · Lancet Infect Dis · 2016-12-03

该研究对2009至2012年上海7982例结核患者中367例耐多药结核患者进行基因分型与全基因组测序,324例有菌株可用。103株(32%)处于38个基因组簇内(SNP差异≤12),提示近期传播;延迟诊断或年龄>45岁者近期传播风险高。传播网络分析显示33/38簇在传播中获得额外耐药突变,68/103簇内菌株有 rifampicin 耐药补偿突变。近期传播驱动上海耐多药结核流行。

要点

  • 324例耐多药菌株中103株(32%)成簇,提示近期传播。
  • 延迟诊断或年龄>45岁与近期传播高风险相关。
  • 33/38簇在传播中累积额外耐药突变,66%成簇菌株有补偿突变。

核心结论

  • 耐多药结核菌株的近期传播并伴随耐药性增加,驱动中国上海耐多药结核流行。
  • 全基因组测序可测量宿主内及宿主间耐药突变异质性,有助于判定耐多药结核传播模式。

研究设计与样本

  • 基于人群的回顾性观察研究,纳入2009年1月1日至2012年12月31日上海结核检测阳性患者。
  • 对分离株进行可变数目串联重复分型与全基因组测序,测量基因组簇内及簇间菌株多样性。
  • 结合基因组与流行病学数据构建传播网络。
  • 7982例结核患者中367例(5%)为耐多药结核,其中324例(88%)有菌株可用于基因组分析。

主要发现

  • 324株耐多药菌株中103株(32%)属于38个基因组簇,簇内菌株SNP差异≤12,提示近期传播。
  • 延迟诊断或年龄>45岁的患者近期传播风险高。
  • 235例(73%)耐多药结核患者可能存在耐多药菌株传播。
  • 传播网络分析显示38个簇中33个(87%)在传播过程中通过突变出现或固定而累积额外耐药突变。
  • 103株成簇耐多药菌株中68株(66%)具有rifampicin耐药补偿突变。

临床怎么用

  • 对耐多药结核患者应尽早诊断,延迟诊断与近期传播高风险相关。
  • 对年龄>45岁耐多药结核患者需关注近期传播风险。
  • 全基因组测序可用于识别耐多药结核传播簇并监测传播中耐药突变累积。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multidrug-resistance is a substantial threat to global elimination of tuberculosis. Understanding transmission patterns is crucial for control of the disease. We used a genomic and epidemiological approach to assess recent transmission of multidrug-resistant (MDR) tuberculosis and identify potential risk factors for transmission. METHODS: We did a population-based, retrospective study of patients who tested positive for tuberculosis between Jan 1, 2009, and Dec 31, 2012, in Shanghai, China. We did variable-number-of-tandem-repeat genotyping and whole-genome sequencing of isolates. We measured strain diversity within and between genomically clustered isolates. Genomic and epidemiological data were combined to construct transmission networks. FINDINGS: 367 (5%) of 7982 patients with tuberculosis had MDR tuberculosis and 324 (88%) of these had isolates available for genomic analysis. 103 (32%) of the 324 MDR strains were in 38 genomic clusters that differed by 12 or fewer single nucleotide polymorphisms (SNPs), indicating recent transmission of MDR strains. Patients who had delayed diagnosis or were older than 45 years had high risk of recent transmission. 235 (73%) patients with MDR tuberculosis probably had transmission of MDR strains. Transmission network analysis showed that 33 (87%) of the 38 clusters accumulated additional drug-resistance mutations through emergence or fixation of mutations during transmission. 68 (66%) of 103 clustered MDR strains had compensatory mutations of rifampicin resistance. INTERPRETATION: Recent transmission of MDR tuberculosis strains, with increasing drug-resistance, drives the MDR tuberculosis epidemic in Shanghai, China. Whole-genome sequencing can measure of the heterogeneity of drug-resistant mutations within and between hosts and help to determine the transmission patterns of MDR tuberculosis. FUNDING: National Science and Technology Major Project, National Natural Science Foundation of China, and US National Insitutes of Health.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Yang C, Luo T, Shen X, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis. 2016. PMID: 27919643. doi:10.1016/S1473-3099(16)30418-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。